Your browser doesn't support javascript.
loading
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing.
Pujol, Pascal; Barberis, Massimo; Beer, Philp; Friedman, Eitan; Piulats, Josep M; Capoluongo, Ettore D; Garcia Foncillas, Jesus; Ray-Coquard, Isabelle; Penault-Llorca, Frédérique; Foulkes, William D; Turnbull, Clare; Hanson, Helen; Narod, Steven; Arun, Banu K; Aapro, Matti S; Mandel, Jean-Louis; Normanno, Nicola; Lambrechts, Diether; Vergote, Ignace; Anahory, Michèle; Baertschi, Bernard; Baudry, Karen; Bignon, Yves-Jean; Bollet, Marc; Corsini, Carole; Cussenot, Olivier; De la Motte Rouge, Thibault; Duboys de Labarre, Marie; Duchamp, Florence; Duriez, Clarisse; Fizazi, Karim; Galibert, Virginie; Gladieff, Laurence; Gligorov, Joseph; Hammel, Pascal; Imbert-Bouteille, Marion; Jacot, William; Kogut-Kubiak, Tatiana; Lamy, Pierre-Jean; Nambot, Sophie; Neuzillet, Yann; Olschwang, Sylviane; Rebillard, Xavier; Rey, Jean-Marc; Rideau, Chloé; Spano, Jean-Philippe; Thomas, Frédéric; Treilleux, Isabelle; Vandromme, Marion; Vendrell, Julie.
Afiliación
  • Pujol P; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France; CREEC, UMR IRD 224-CNRS 5290 Université Montpellier, Montpellier, France. Electronic address: p-pujol@chu-montpellier.fr.
  • Barberis M; Pathology Unit, European Institute of Oncology, Milan, Italy. Electronic address: Massimo.barberis@ieo.it.
  • Beer P; Wellcome Trust Sanger institute, Cambridge, United Kingdom; Glasgow Precision Oncology Laboratory, United Kingdom. Electronic address: pbeer@doctors.org.uk.
  • Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. Electronic address: Eitan.Friedman@sheba.health.gov.il.
  • Piulats JM; Unidad Funcional de Cáncer de Próstata, Servicio de Oncología Médica, Hospital Universitari de Bellvitge-Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Spain; Servicio de Oncología Médica, Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Spain. Electronic address: jmpiulats@i
  • Capoluongo ED; Dipartimento di Medicina Molecolare e Biotecnologie Mediche Università Federico II, CEINGE Biotecnologie Avanzate, Naples, 80145, Italy. Electronic address: ettoredomenico.capoluongo@unina.it.
  • Garcia Foncillas J; Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jimenez Diaz-UAM, Madrid, Spain. Electronic address: jesus.garciafoncillas@oncohealth.eu.
  • Ray-Coquard I; Oncologie Médicale, Centre Leon Bérard; Univ Lyon, Université Claude Bernard Lyon1, Hesper EA 7425, F - 69003, Lyon, France. Electronic address: Isabelle.Ray-Coquard@lyon.unicancer.fr.
  • Penault-Llorca F; Department of Biology and Pathology, Centre Jean Perrin, Clermont Ferrand, France; UMR INSERM 1240, Université Clermont Auvergne, Clermont Ferrand, France. Electronic address: Frederique.PENAULT-LLORCA@cjp.fr.
  • Foulkes WD; McGill University, Division of Medical Genetics, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada. Electronic address: william.foulkes@mcgill.ca.
  • Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Genomics England, Queen Mary University of London, London, UK; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Clare.Turnbull@genomicsengland.co.uk.
  • Hanson H; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. Electronic address: helen.hanson@icr.ac.uk.
  • Narod S; University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada; Canada Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. Electronic address: Steven.Narod@wchospital.ca.
  • Arun BK; Anderson Cancer Center, The University of Texas, Department of Breast Medical Oncology, Division of Cancer Medicine, USA. Electronic address: barun@mdanderson.org.
  • Aapro MS; IMO Clinique de Genolier, Genolier, Switzerland. Electronic address: Maapro@genolier.net.
  • Mandel JL; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France; Université de Strasbourg, Illkirch, France. Electronic address: jlmandel@igbmc.fr.
  • Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy. Electronic address: n.normanno@istitutotumori.na.it.
  • Lambrechts D; Laboratory of Translational Genetics (VIB-KU Leuven), ON IV Herestraat 49 - box 912, 3000, Leuven Belgium. Electronic address: diether.lambrechts@kuleuven.vib.be.
  • Vergote I; Department of Gynaecologic Oncology University Hospitals Leuven, Gasthuisberg Herestraat 49, 3000 Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be.
  • Anahory M; Pech de Laclause, Bathmanabane & Associés Law Firm, Paris, France. Electronic address: manahory@pechdelaclause.com.
  • Baertschi B; French National Institute for Health and Medical Research (INSERM) Ethics Committee, France University of Geneva, Geneva, Switzerland. Electronic address: bernard.baertschi@unige.ch.
  • Baudry K; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: k-baudry@chu-montpellier.fr.
  • Bignon YJ; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France; INSERM-U1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France. Electronic address: Yves-Jean.Bignon@cjp.fr.
  • Bollet M; Institut Hartmann, 4, rue Kléber, et Institut Rafael, 3 bd Bineau, 92309 Levallois-Perret cedex, France. Electronic address: marc.bollet@horg.fr.
  • Corsini C; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: c-corsini@chu-montpellier.fr.
  • Cussenot O; CeRePP, Hopital Tenon, Paris, France; Sorbonne Université, Institut Universitaire de Cancérologie, GRC n°5 ONCOTYPE-URO, Hopital Tenon, APHP, Paris, France; Department of Urology, Assistance Publique- Hôpitaux de Paris, Hopital Tenon, Paris, France. Electronic address: olivier.cussenot@tnn.aphp.fr.
  • De la Motte Rouge T; Inserm, Oncogenesis, Stress and Signaling, 35000 Rennes, France; Service d'oncologie médicale, CRLCC Eugène-Marquis, 35000 Rennes, France; UMR 1242, Inserm, Univ Rennes, CLCC Eugène Marquis, Rue Bataille Flandres Dunkerque, 35042, Rennes, France. Electronic address: t.delamotterouge@rennes.unicancer
  • Duboys de Labarre M; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: m-duboysdelabarre@chu-montpellier.fr.
  • Duchamp F; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: f-duchamp@chu-montpellier.fr.
  • Duriez C; BRCA France Association, France. Electronic address: duriez.clarisse@gmail.com.
  • Fizazi K; Institut Gustave Roussy and University of Paris Sud, Villejuif, France. Electronic address: karim.FIZAZI@gustaveroussy.fr.
  • Galibert V; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: v-galibert@chu-montpellier.fr.
  • Gladieff L; Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address: Gladieff.Laurence@iuct-oncopole.fr.
  • Gligorov J; APHP-Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr.
  • Hammel P; Department of Pancreatology, Hôpital Beaujon (AP-HP), Université Denis Diderot-Paris VII, Clichy, France. Electronic address: pascal.hammel@bjn.aphp.fr.
  • Imbert-Bouteille M; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: m-imbert-bouteille@chu-montpellier.fr.
  • Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France; Translational Research Unit, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France. Electronic address: William.Jacot@ic
  • Kogut-Kubiak T; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: t-kogutkubiak@chu-montpellier.fr.
  • Lamy PJ; Institut d'analyse génomique-Imagenome, Labosud, Montpellier, France. Electronic address: pierre-jean.lamy@labosud.fr.
  • Nambot S; Centre de Génétique et Centre de Référence Maladies Rares (Anomalies du Développement de l'Interrégion Est), Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France; Inserm UMR 1231 GAD (Génétique des Anomalies du Développement), Université de Bourgogne, Dijon, France; Fédération Hospitalo-Universitai
  • Neuzillet Y; Service d'urologie et de transplantation rénale, hôpital Foch, université de Versailles - Saint-Quentin-en-Yvelines, 40, rue Worth, 92150 Suresnes, France. Electronic address: y.neuzillet@hopital-foch.org.
  • Olschwang S; Aix Marseille Université, INSERM GMGF UMR 1251, France; Département de Génétique Médicale, Hôpital Européen & Groupe Ramsay Générale de Santé, Hôpital Clairval, Aix Marseille Université, Marseille, France. Electronic address: solschwang@gmail.com.
  • Rebillard X; Service d'Urologie, Clinique Beausoleil, Montpellier, France. Electronic address: xavier.rebillard@wanadoo.fr.
  • Rey JM; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: jm-rey@chu-montpellier.fr.
  • Rideau C; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: c-rideau@chu-montpellier.fr.
  • Spano JP; Department of Medical Oncology, Hôpital Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France; Inserm UMRS 1136, Sorbonne Université, Paris, France. Electronic address: jean-philippe.spano@psl.aphp.fr.
  • Thomas F; IRD, CREEC et MIVE911 avenue Agropolis, BP 64501, Montpellier 34 394, France. Electronic address: frederic.thomas2@ird.fr.
  • Treilleux I; Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France. Electronic address: isabelle.treilleux@lyon.unicancer.fr.
  • Vandromme M; BRCA France Association, France. Electronic address: marion.vandromme@gmail.com.
  • Vendrell J; IRCM, INSERM 1194, Department of Pathology and Oncobiology, Laboratoire de biologie des tumeurs solides, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: j-vendrell@chu-montpellier.fr.
Eur J Cancer ; 146: 30-47, 2021 03.
Article en En | MEDLINE | ID: mdl-33578357
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Pruebas Genéticas / Guías de Práctica Clínica como Asunto / Mutación de Línea Germinal / Proteína BRCA1 / Proteína BRCA2 Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Aspecto: Ethics Límite: Female / Humans Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Pruebas Genéticas / Guías de Práctica Clínica como Asunto / Mutación de Línea Germinal / Proteína BRCA1 / Proteína BRCA2 Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Aspecto: Ethics Límite: Female / Humans Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido